Research Article
Diagnostic Accuracy of the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC): An Institution Experience
Table 4
Risk of malignancy for each Bethesda category.
| Bethesda category | Institutional risk of malignancy (%) N = 855 | Estimated risk of malignancy in TBSRTC (%) [8] | Risk of malignancy in Inabnet et al. (%) [17] N = 21,746 | Risk of malignancy in Nayar and Ivanovic (%) [18] N = 5194 | Risk of malignancy in Voung et al. (%) [19] N = 145,066 |
| I | 2.7–100 | 5–10 | 19.2 | 9 | 2.0–19.1 | II | 0 | 0–3 | 12.7 | 2 | 0.7–8.0 | III | 4.6–40 | 6–18 | 31.9 | 6 | 9.2–30.5 | IV | 15.4–20 | 10–40 | 31.4 | 14 | 28.9 | V | 61.1 | 45–60 | 77.8 | 53 | 79.6 | VI | 95–100 | 94–96 | 96.0 | 97 | 99.1 |
|
|